Figure 3.1 Death Rates by States All Dialysis Patients

Slides:



Advertisements
Similar presentations
The results of the Study of Heart and Renal Protection (SHARP)
Advertisements

Cancer 101 Monica Schlatter, RN, ND, AOCNP. Types of Cancer AIDS- related malignancies AIDS- related malignancies Bone and soft tissue sarcoma Bone and.
The results of the Study of Heart and Renal Protection (SHARP) Colin Baigent, Martin Landray on behalf of the SHARP Investigators Disclosure: SHARP was.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
Cancer Card Game Answers etc.
ANZDATA Registry Annual Report 2013 CANCER CHAPTER 10.
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
NEW PATIENTS COMMENCING TREATMENTS IN 2010 CHAPTER 2.
ANZDATA Registry Annual Report 2013 NEW PATIENTS CHAPTER 2.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Recurrence of Malignancy after Transplantation ANZDATA - Australian and New Zealand Dialysis and Transplant Registry NSW Cancer Council.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN Annual Report—35th Edition ANZDATA Registry Annual Report.
Chapter 1 Incidence of End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.
EEOICPA Compensation Results (through March 2004) Russ Henshaw, MS Epidemiologist NIOSH/Office of Compensation Analysis & Support Cincinnati, OH.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
CANCER.  Cancer is a group of more than 200 diseases characterized by unregulated growth of cells.  This growth of new cells is called a tumor.  Tumors.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
RT-PCR: RBP-MS, T52 T53 (427 bp), Reamplifikation _Reampli_Gewebe_1_B1_T52T53_calb Bedingungen: 2% TBE 90V 1h 45min 9 µ Reampli-Probe 2 µl LB M 1.
Cancer Facts MS JYOTI SHAH CONSULTANT UROLOGICAL SURGEON SOURCE: CANCER RESEARCH UK.
OrganNumber waiting list Dec 08Number Transplant 07/08 Kidney Liver Pancreas83224 Heart Lung Total10,
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Australian Kidney Transplant Waiting List Stock and Flow
Survival in most affluent
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Non-Communicable Diseases Lesson 7
Number of Grafts Performed by Country
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
بسم الله الرحمن الرحيم.
The results of the SHARP trial
ANZDATA Registry Annual Report 2013
The 20 Most Common Cancers in 2012
Volume 74, Issue 5, Pages (September 2008)
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
The results of the SHARP trial
American Journal of Kidney Diseases
・FFPE tumor tissue array (Biochain, cat. T )
Number of Donors in Australia
International Donor Statistics 2000
Survival of End Stage Renal Failure Patients with Cancer
Number of Donors in Australia
International Donor Statistics 1999
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Peritoneal Dialysis Patients Australia
Presentation transcript:

Figure 3.1 Death Rates by States 1995 - 2001 All Dialysis Patients (per 100 patient years) Year Qld NSW ACT Vic. Tas. SA NT WA Aust. N. Z. 1995 16.8 13.8 11.4 15.4 18.6 16.2 20.2 13.1 15.0 19.0 1996 17.7 14.2 14.0 14.6 23.5 23.1 14.5 15.6 14.8 1997 16.5 16.7 12.2 12.5 15.3 20.5 18.4 17.1 15.8 15.9 1998 19.3 16.9 25.9 15.7 13.6 16.6 1999 20.7 16.0 14.7 14.1 23.9 15.2 17.6 17.3 16.4 2000 13.5 14.3 20.0 16.3 19.2 2001 23.4 21.9

Dialysis Modality & Age Groups 2001 Figure 3.2 Death Rates by States Dialysis Modality & Age Groups 2001 (per 100 patient years) Age Group Treatment Qld NSW ACT Vic. Tas. SA NT WA Aust. N.Z. 45-64 yrs All Patients 14.1 11.5 6.3 11.1 18.8 9.7 17.2 16.5 12.5 17.3 PD 13.0 11.4 0.0 11.3 13.6 60.2 14.2 12.4 19.6 HD 14.6 9.0 21.4 12.1 17.5 15.1 65-84 yrs 27.3 23.6 28.2 20.7 36.2 21.6 18.2 34.0 24.4 30.8 22.8 28.1 30.3 22.0 29.6 30.9 38.9 26.3 29.3 26.6 20.5 39.7 19.2 32.0 36.7

Cause of Death Dialysis and Transplant Dependent Figure 3.3 Cause of Death Dialysis and Transplant Dependent 1-Jan-2001 to 31-Dec-2001 Cause of Death Australia New Zealand Dialysis Transplant Cardiac Cardiac Arrest 176 14 28 3 Haemorrhagic Pericarditis 2 Hyperkalaemia 10 1 Hypertensive Cardiac Failure 6 Myocardial Infarction 128 21 Myocardial Infarction (presumed) 119 7 45 Other Causes of Cardiac Failure 33 4 Pulmonary Oedema Sub Total 480 (44%) 50 (34%) 110 (42%) 6 (26%) Infection CNS - fungal 2 (g) Lung - bacterial 24 Lung - viral 2 (a,b) 1 (e) Lung - fungal 1 (c) 5 (c,g) Lung - other 7 (j) 1 (j) Urinary Tract - bacterial Wound - bacterial 8 Shunt - bacterial Peritoneum - bacterial 18 Peritoneum - fungal 3 (d) 1 (d) Peritoneum - other Septicaemia - bacterial 29 5 Septicaemia - viral 2 (e,f) Septicaemia - fungal 2 (c,d) Septicaemia - protozoa 1 (i) Septicaemia - other 9 (j) 2 (j) 5 (j) Liver - bacterial Other Site - bacterial 22 Other Site - viral 1 (h) Other Site - other SubTotal 135 (13%) 23 (15%) 31 (12%) 3 (13%) Vascular Bowel Infarction 25 Cerebrovascular Accident 69 9 Gastrointestinal Haemorrhage Haemorrhage - dialysis access site Haemorrhage - elsewhere Haemorrhage - transplant artery Pulmonary Embolus Ruptured Aortic Aneurysm 106 (10%) 14 (9%) 34 (13%) 2 (9%) Social Accident Patient refused further treatment 152 40 Suicide Therapy ceased 86 12 245 (23%) 4 (3%) 56 (21%) 1 (4%) Miscellaneous Cachexia Chronic Respiratory Failure Hepatic Failure Malignancy 63 37 16 Other 15 Pancreatitis Perforation Abdominal Viscus Sclerosing Peritonitis Unknown Uraemia - graft failure 113 (10%) 58 (39%) 30 (12%) 11 (48%) Total 1079 (100%) 149 (100%) 261 (100%) 23 (100%) (a) Herpes Zoster (b) Virus not isolated (c) Aspergillus (d) Candida (e) CMV (f) Varicella (g) Cryptococcus (h) Rotavirus (i) Toxoplasmosis (j) Organism not isolated

Death as a Proportion of Dialysis Treated Patients 1997 - 2001 Figure 3.4 Death as a Proportion of Dialysis Treated Patients 1997 - 2001 1997 1998 1999 2000 2001 Australia All Dialysis 12.3% 12.9% 12.8% PD 11.4% 11.9% 11.8% HD 10.9% 11.3% 11.2% 11.7% All Patients 55-64 years 14% 12% 12.5% 10.4% 9% 9.9% 8.7% 13% 11% 9.1% All Patients 65-74 years 18% 19% 16.7% 16.6% 16% 14.1% 15.8% 17% 15.6% 14.9% New Zealand 12.7% 12.6% 14.8% 14.3% 12.1% 10.6% 14.7% 13.8% 8.8% 9.7%

Dialysis and Transplant Patient Deaths Q Figure 3.5 Dialysis and Transplant Patient Deaths Q Deaths as a Proportion of All Patients Treated During the Year 2001 Mode of Treatment No. of Pts. Age Groups Total Deaths 00-04 05-14 15-24 25-34 35-44 45-54 55-64 65-74 75-84 > 85 Australia All Patients Peritoneal Dialysis 2614 0% 3% 5% 8% 9% 16% 21% 29% 11.8% (310) Haemodialysis 6568 2% 7% 11% 15% 40% 11.7% (769) All Dialysis Pts 8406 17% 23% 12.8% (1079) Transplant Pts 5784 5.5% 1% <1% 2.5% (149) Diabetic Patients 641 6% 12% 19% 28% 15.1% (97) 1224 20% 14.0% (172) All Diabetic Dx 1671 18% 25% 16.0% (269) Diabetic Tx 419 3.5% (15) Non Diabetic Patients 1973 4% 33% 10.7% (213) 5344 10% 41% 11.1% (597) Non Diabetic Pts 6735 42% 12.0% (810) Non Diabetic Tx 5365 17.5% 2.4% (134) New Zealand 974 36% 13.8% (135) 1055 13% 11.9% (126) 1823 31% 30% 38% 14.3% (261) 1130 7.5% 2.0% (23) 377 22% 27% 18.5% (70) 338 54% 14.4% (49) 637 14% 48% 18.6% (119) 102 1.9% (2) 597 10.8% (65) 717 10.7% (77) 1186 11.9% (142) 1028 2.0% (21) [ Expressed as (%) of all patients, non diabetic, and diabetic patients treated by dialysis or with a functioning transplant in 2001 Note: some patients will have been treated by both peritoneal dialysis and haemodialysis

Death Rates, Dialysis Patients 2001 Figure 3.6 Australia Death Rates, Dialysis Patients 2001 (per 100 patient years) H Treatment at Death Age Groups 00-14 15-24 25-44 45-64 65-84 > 85 All Ages All Dialysis All Patients Death Rate 3.0 5.4 12.5 24.4 60.3 16.2 No. of Deaths 4 66 306 673 30 1079 No. at Risk 49 171 1504 3080 3531 71 8406 Diabetic Death Rate 12.2 20.3 26.4 21.3 23 120 126 269 254 785 626 2 1671 Non Diabetic Death Rate 42 10.0 24.0 62.1 15.1 43 186 547 810 167 1250 2295 2905 69 6735 Peritoneal Dialysis 4.8 5.5 26.6 49.4 17.7 15 78 208 7 310 36 63 396 1916 1180 2614 8.0 20.5 361 24.3 5 38 54 97 293 247 641 4.9 4.7 9.2 55.0 15.7 10 40 154 213 61 299 623 933 21 1973 Haemodialysis 2.2 12.4 23.6 64.66 15.8 51 228 465 769 17 124 1245 2454 2675 53 6568 14.4 20.2 21.9 20.0 18 82 72 172 188 592 442 1224 4.0 10.2 23.9 64.7 14.8 33 146 393 597 122 1057 1862 2233 5344

Death Rates, Transplant Patients 2001 Figure 3.7 Australia Death Rates, Transplant Patients 2001 (per 100 patient years) Age Groups 00-04 05-14 15-24 25-34 35-44 45-54 55-64 65-74 75-84 All Ages All Transplants All Patients Death Rate 7.4 1.0 0.9 0.3 0.7 1.6 5.0 7.9 18.2 2.8 No. of Deaths 1 2 8 22 57 46 10 149 No. at Risk 18 108 265 778 1202 1494 1235 621 60 5784 Diabetic Death Rate 2.5 3.2 11.1 7.7 4.0 3 4 7 15 56 134 139 76 13 419 Non Diabetic Death Rate 0.5 1.4 4.6 18.6 2.7 5 50 45 722 1068 1355 1159 608 59 5365 Cadaver Transplants 1.1 0.2 1.8 5.3 8.4 14.9 3.4 20 53 137 38 105 478 856 1198 1064 571 58 4369 3.1 3.8 11.3 9.1 4.5 6 14 47 115 62 11 344 15.2 3.3 16 44 123 431 748 1083 1002 560 4025 Living Donor Transplants 0.4 0.8 2.6 2.2 158.7 12 17 70 160 300 348 297 171 1415 9.7 9 26 24 75 2.1 2.3 291 322 273 157 48 1340

Death Rates, Dialysis Patients 2001 Figure 3.8 New Zealand Death Rates, Dialysis Patients 2001 (per 100 patient years) H Treatment at Death Age Groups 00-14 15-24 25-44 45-64 65-84 > 85 All Ages All Dialysis All Patients Death Rate 9.8 3.9 6.0 17.3 30.8 59.7 18.6 No. of Deaths 1 2 16 117 120 5 261 No. at Risk 67 340 862 526 12 1823 Diabetic Death Rate 11.4 23.4 34.7 24.6 6 75 38 119 66 422 149 637 Non Diabetic Death Rate 4.6 11.8 29.2 15.4 10 42 82 142 274 440 377 1186 Peritoneal Dialysis 4.8 6.8 19.6 26.3 53.0 19.5 7 64 59 4 135 13 29 147 448 326 11 974 14.8 33.3 26.7 46 20 70 39 246 92 23.8 15.2 3 18 65 108 202 234 597 Haemodialysis 47.6 3.3 5.4 15.1 36.7 120.5 17.6 9 53 61 126 44 227 508 268 1055 7.9 19.8 36.4 22.1 49 37 225 76 338 5.0 36.9 15.6 24 43 77 190 283 192 717

Death Rates, Transplant Patients 2001 Figure 3.9 New Zealand Death Rates, Transplant Patients 2001 (per 100 patient years) Age Groups 00-04 05-14 15-24 25-34 35-44 45-54 55-64 65-74 75-84 All Ages All Transplants All Patients Death Rate 0.8 1.1 5.2 8.0 2.2 No. of Deaths 2 3 9 8 1 23 No. at Risk 4 22 57 173 272 290 191 103 13 1130 Diabetic Death Rate 3.3 3.8 5 29 34 102 Non Diabetic Death Rate 0.9 5.4 8.4 21 168 243 256 162 1027 Cadaver Transplants 7.7 2.6 7 19 18 87 190 228 163 98 12 806 4.4 4.1 2.5 26 25 27 88 1.3 0.5 5.6 8.1 17 82 164 203 136 93 718 Living Donor Transplants 1.8 4.0 11.4 217.4 1.4 14 39 86 62 28 323 2.1 79 53 309

Deaths from Malignancy 2001 Dialysis and Transplant Dependent Figure 3.10 Deaths from Malignancy 2001 Dialysis and Transplant Dependent Dx Tx Total Australia Adenocarcinoma Breast 7 (#6) 7 Caecum 1 Colon 2 3 Kidney 4 (#4) 5 Lung 5 (#1) Oesophagus Ovary 1 (#1) Rectosigmoid Rectum Stomach 1 (*1) Leukaemia Lymphoproliferative Disease Transplant kidney Lymphoma Bone Marrow Groin node Neck node Node - other Peritoneum Melanoma Forehead Eye Merkel Cell Myeloma 11 (#10) 11 Squamous Cell Carcinoma Cervix Iliac fossa Skin 8 10 Tonsils Transitional Cell Carcinoma Bladder 2 (*1)(#1) 2 (#2) Ureter Other Adrenocortical - adrenal gland Ewing's Sarcoma - kidney Fibroxanthoma - skin Glioblastoma - brain Hepatoma - liver Large Cell - lung Mesothelioma - lung Mucinous - colon Myxoid Liposarcoma - thigh Neuro-endocrine - lung Non Small Cell - lung Small Cell - lung 4 Spindle Cell - lung Unknown - basal ganglia Unknown - lung Unknown - unknown site Total Deaths from Malignancy 63 37 100 * (2 patients) previous transplants # (31 patients) diagnosed pre dialysis or within two months of commencing New Zealand 3 (#1) Gastro-oesophageal Pancreas Unknown site Ethnoid sinus Jaw Post Auricular Bronchus Papillary - omentum 16 6 22 No dialysis patients had a previous transplant # (5 patients) diagnosed pre dialysis or within two months